Non–AIDS-Defining Cancers

  • Authors: David Aboulafia, MD; Liron Pantanowitz, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 12/12/16 (What's New)

Summary

  • HCC screening recommended in HIV-infected patients with HBV or HCV coinfection, although not yet prospectively assessed (Management Guidelines)[Bower 2014]
  • HIV-infected patients with HCC less likely to be retreated at recurrence, leading to decrease in OS vs HIV-negative patients with HCC[Berretta 2011]
  • In transplant setting, significant potential exists for adverse drug interactions between ART and immunosuppressive therapy[Antonini 2004; Rudek 2011]

Action required

Keywords: Cancer, Drug-Drug Interactions, Viral Hepatitis Coinfection

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.